SPOCK1
Basic information
Region (hg38): 5:136975298-137598379
Previous symbols: [ "TIC1", "SPOCK" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SPOCK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 27 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 27 | 5 | 1 |
Variants in SPOCK1
This is a list of pathogenic ClinVar variants found in the SPOCK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-136978716-C-T | not specified | Uncertain significance (Apr 12, 2024) | ||
5-136978733-C-G | not specified | Uncertain significance (Nov 08, 2022) | ||
5-136988483-G-C | not specified | Uncertain significance (Apr 13, 2022) | ||
5-136988503-G-T | not specified | Uncertain significance (Dec 20, 2023) | ||
5-136988518-C-T | not specified | Uncertain significance (May 17, 2023) | ||
5-136988534-G-T | SPOCK1-related disorder | Likely benign (Aug 14, 2019) | ||
5-136988566-G-C | not specified | Uncertain significance (Mar 22, 2023) | ||
5-136988596-T-C | not specified | Uncertain significance (Feb 10, 2022) | ||
5-136988629-T-C | not specified | Uncertain significance (Jul 11, 2023) | ||
5-136992523-T-C | not specified | Uncertain significance (Dec 27, 2023) | ||
5-136992552-C-A | not specified | Uncertain significance (Mar 22, 2023) | ||
5-136992580-G-A | not specified | Uncertain significance (Jun 22, 2023) | ||
5-137067739-G-C | not specified | Uncertain significance (Sep 28, 2022) | ||
5-137067781-G-T | not specified | Uncertain significance (Aug 13, 2021) | ||
5-137067787-C-T | not specified | Likely benign (Apr 08, 2022) | ||
5-137067796-T-C | not specified | Uncertain significance (Jun 22, 2023) | ||
5-137067817-A-G | not specified | Uncertain significance (May 27, 2022) | ||
5-137112481-T-C | not specified | Uncertain significance (Jan 16, 2024) | ||
5-137112488-C-T | not specified | Uncertain significance (Jun 30, 2023) | ||
5-137112490-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
5-137112496-G-T | not specified | Uncertain significance (Feb 28, 2023) | ||
5-137112511-A-C | not specified | Uncertain significance (Mar 22, 2023) | ||
5-137112516-C-T | SPOCK1-related disorder | Likely benign (Feb 28, 2019) | ||
5-137112517-G-A | not specified | Uncertain significance (Apr 13, 2022) | ||
5-137112517-G-C | not specified | Uncertain significance (Apr 11, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SPOCK1 | protein_coding | protein_coding | ENST00000394945 | 10 | 623082 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.826 | 0.174 | 125732 | 0 | 14 | 125746 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.18 | 190 | 242 | 0.786 | 0.0000124 | 2886 |
Missense in Polyphen | 71 | 103.28 | 0.68747 | 1268 | ||
Synonymous | -0.0533 | 103 | 102 | 1.01 | 0.00000579 | 790 |
Loss of Function | 3.71 | 4 | 23.4 | 0.171 | 0.00000108 | 272 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000116 | 0.000116 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.0000928 | 0.0000924 |
European (Non-Finnish) | 0.0000441 | 0.0000440 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play a role in cell-cell and cell-matrix interactions. May contribute to various neuronal mechanisms in the central nervous system.;
- Pathway
- Adipogenesis
(Consensus)
Recessive Scores
- pRec
- 0.206
Intolerance Scores
- loftool
- 0.542
- rvis_EVS
- -0.49
- rvis_percentile_EVS
- 22.51
Haploinsufficiency Scores
- pHI
- 0.288
- hipred
- Y
- hipred_score
- 0.513
- ghis
- 0.606
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0552
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Spock1
- Phenotype
- normal phenotype;
Gene ontology
- Biological process
- regulation of cell growth;neuron migration;cell adhesion;nervous system development;negative regulation of cell-substrate adhesion;negative regulation of endopeptidase activity;negative regulation of neuron projection development;central nervous system neuron differentiation;neurogenesis
- Cellular component
- extracellular space;cytoplasm;postsynaptic density;sarcoplasm;neuromuscular junction;node of Ranvier
- Molecular function
- serine-type endopeptidase inhibitor activity;cysteine-type endopeptidase inhibitor activity;calcium ion binding;collagen binding;metalloendopeptidase inhibitor activity;extracellular matrix binding